dehydroepiandrosterone has been researched along with tamoxifen in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (31.11) | 18.7374 |
1990's | 8 (17.78) | 18.2507 |
2000's | 13 (28.89) | 29.6817 |
2010's | 7 (15.56) | 24.3611 |
2020's | 3 (6.67) | 2.80 |
Authors | Studies |
---|---|
Bellavance, E; Luu-The, V; Poirier, D | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brogi, S; Papazafiri, P; Roussis, V; Tafi, A | 1 |
Purohit, A; Reed, MJ | 1 |
Eechaute, W; Lacroix, E; Leusen, I; Vanderstichele, H | 1 |
Bird, CE; Clark, AF; Masters, V; Sterns, EE | 1 |
Carlström, K; Pousette, A; Rannevik, G; Sköldefors, H; Theve, NO; Wilking, N | 1 |
Fletcher, WS; Keenan, EJ; Pommier, RF; Woltering, EA | 1 |
Gurpide, E; Markiewicz, L | 1 |
Gerhard, I; Runnebaum, B | 1 |
Bozek, T; Carr, L; Dowsett, M; Gazet, JC; Jeffcoate, SL; Kurkure, A; McKinna, JA; Smith, IE; Stuart-Harris, R | 1 |
Murray, RM; Pitt, P | 1 |
Carlström, K; Sköldefors, H; Theve, NO; Wallgren, A; Wilking, N | 1 |
Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N | 1 |
Blackburn, AM; Bulbrook, RD; Hoare, SA; Kwa, HG; Rubens, RD; Thomas, BS; Wang, DY | 1 |
Smith, IE; Stuart-Harris, RC | 1 |
Helgason, S | 1 |
Davis, TE; Rose, DP | 1 |
Santen, RJ; Santner, SJ | 1 |
Brentani, MM; Liberato, MH; Sonohara, S | 1 |
O'Shaughnessy, JA | 1 |
Bowman-Gram, TA; Johnson, WD; Kellof, GJ; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
Coe, JE | 1 |
Boone, CW; Crowell, JA; Hawk, ET; Kelloff, GJ; Lubet, RA; Nayfield, SG; Sigman, CC; Steele, VE | 1 |
Fletcher, WS; Lum, SS; Pommier, RF; Woltering, EA | 1 |
Grubbs, CJ; Khan, SA; Lubet, RA; Nephew, KP; Osborne, E | 1 |
Cyr, M; Di Paolo, T; Landry, M | 1 |
Nakayama, Y; Sakamoto, H; Satoh, K; Yamamoto, T | 1 |
Klinga, K; Mayer, D; Morfin, R; Schmitt, M; Schnarr, B | 1 |
Kagaya, A; Kurata, K; Morinobu, S; Takebayashi, M; Yamawaki, S | 1 |
Barker, JL; Chang, YH; Li, Bs; Ma, W; Rubinow, DR; Zhang, L; Zhao, W | 1 |
Nakajima, A; Sekihara, H; Takahashi, H | 1 |
Dillon, JS; Liu, D | 1 |
Angele, MK; Chaudry, IH; Faist, E; Frantz, MC; Hernandez-Richter, T; Jauch, KW; Prix, NJ; van den Engel, NK; Wichmann, MW | 1 |
Labrie, F | 1 |
Benninghoff, AD; Williams, DE | 1 |
Ballard-Barbash, R; Baumgartner, KB; Baumgartner, RN; Bernstein, L; Gilliland, F; Koprowski, C; McTiernan, A; Neuhouser, ML; Ulrich, CM; Wayne, S; Wiggins, C | 1 |
Bryk, M; Chatterton, RT; Habe-Evans, M; Khan, SA; Parker, NP; Scholtens, DM | 1 |
Duffel, MW; Qin, X; Squirewell, EJ | 1 |
Atherton, PJ; Barton, DL; Birrell, SN; Dockter, T; Griffin, P; Lafky, JM; Loprinzi, CL; Mattar, B; Shuster, LT; Sood, R; Terstriep, SA; Thielen, J | 1 |
Shifren, JL | 1 |
Files, J; Kling, JM; Vegunta, S | 1 |
Eckert, LO; Kus, LH; Neal, CM; Peipert, JF | 1 |
Chang, Y; Duan, H; Li, B; Wang, S | 1 |
8 review(s) available for dehydroepiandrosterone and tamoxifen
Article | Year |
---|---|
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
Hormonal influence on hepatocarcinogenesis.
Topics: Animals; Cricetinae; Dehydroepiandrosterone; Gonadal Steroid Hormones; Hormones; Humans; Liver Neoplasms; Tamoxifen | 1996 |
Perspectives and progress in development of breast cancer chemopreventive drugs.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Dehydroepiandrosterone; Estrogen Antagonists; Female; Fenretinide; Humans; Risk Factors; Tamoxifen | 1997 |
Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy.
Topics: Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone; Estrogen Antagonists; Female; Hormone Replacement Therapy; Humans; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Neoplasms | 2007 |
Genitourinary Syndrome of Menopause.
Topics: Administration, Intravaginal; Administration, Oral; Atrophy; Dehydroepiandrosterone; Dyspareunia; Estrogens; Female; Humans; Laser Therapy; Lower Urinary Tract Symptoms; Lubricants; Menopause; Physical Therapy Modalities; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vulva | 2018 |
Noncandidal vaginitis: a comprehensive approach to diagnosis and management.
Topics: Administration, Intravaginal; Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents; Atrophic Vaginitis; Candidiasis, Vulvovaginal; Clindamycin; Dehydroepiandrosterone; Diagnosis, Differential; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hydrocortisone; Inflammation; Lichen Planus; Metronidazole; Pemphigoid, Benign Mucous Membrane; Pemphigoid, Bullous; Pemphigus; Tamoxifen; Tinidazole; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial | 2020 |
Drugs for menopausal symptoms.
Topics: Animals; Cimicifuga; Dehydroepiandrosterone; Estrogens; Female; Flax; Hot Flashes; Humans; Menopause; Progestins; Tamoxifen | 2020 |
Efficacy and safety of current therapies for genitourinary syndrome of menopause: A Bayesian network analysis of 29 randomized trials and 8311 patients.
Topics: Bayes Theorem; Dehydroepiandrosterone; Estrogens; Female; Female Urogenital Diseases; Humans; Laser Therapy; Menopause; Network Meta-Analysis; Randomized Controlled Trials as Topic; Syndrome; Tamoxifen; Treatment Outcome | 2021 |
4 trial(s) available for dehydroepiandrosterone and tamoxifen
Article | Year |
---|---|
Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Menopause; Ovary; Prednisolone; Prolactin; Receptors, Estrogen; Tamoxifen; Thyroxine | 1984 |
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
Perspectives and progress in development of breast cancer chemopreventive drugs.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Dehydroepiandrosterone; Estrogen Antagonists; Female; Fenretinide; Humans; Risk Factors; Tamoxifen | 1997 |
Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
Topics: Administration, Intravaginal; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Genital Neoplasms, Female; Gonadal Steroid Hormones; Humans; Middle Aged; Osteogenesis; Postmenopause; Tamoxifen; Testosterone; Vagina | 2018 |
35 other study(ies) available for dehydroepiandrosterone and tamoxifen
Article | Year |
---|---|
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
3D-QSAR using pharmacophore-based alignment and virtual screening for discovery of novel MCF-7 cell line inhibitors.
Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; High-Throughput Screening Assays; Humans; MCF-7 Cells; Molecular Structure; Quantitative Structure-Activity Relationship; Structure-Activity Relationship | 2013 |
Oestrogen sulphatase activity in hormone-dependent and hormone-independent breast-cancer cells: modulation by steroidal and non-steroidal therapeutic agents.
Topics: Breast Neoplasms; Cell Division; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Humans; Kinetics; Receptors, Estrogen; Receptors, Progesterone; Sulfatases; Tamoxifen; Tumor Cells, Cultured | 1992 |
Effect of tamoxifen on the activity of enzymes of testicular steroidogenesis.
Topics: 20-Hydroxysteroid Dehydrogenases; Androstenedione; Animals; Dehydroepiandrosterone; Follicle Stimulating Hormone; Luteinizing Hormone; Lyases; Male; Organ Size; Progesterone; Rats; Rats, Inbred Strains; Steroid 17-alpha-Hydroxylase; Tamoxifen; Testicular Hormones; Testis; Testosterone | 1989 |
Effects of tamoxifen on testosterone metabolism in postmenopausal women with breast cancer.
Topics: Aged; Breast Neoplasms; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Female; Humans; Kinetics; Luteinizing Hormone; Menopause; Metabolic Clearance Rate; Middle Aged; Receptors, Estrogen; Tamoxifen; Testosterone | 1985 |
Endocrine treatment of breast cancer: effects upon intratumoral estrone sulfate metabolism and peripheral steroid levels.
Topics: Aminoglutethimide; Breast Neoplasms; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Estrogens; Estrone; Female; Humans; Pregnadienes; Sex Hormone-Binding Globulin; Tamoxifen | 1986 |
The mechanism of hormone-sensitive breast cancer progression on antiestrogen therapy. Implications for treatment and protocol planning.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aged; Breast Neoplasms; Castration; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hypophysectomy; Middle Aged; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Stimulation, Chemical; Tamoxifen | 1987 |
C19 adrenal steroids enhance prostaglandin F2 alpha output by human endometrium in vitro.
Topics: Androstanes; Androstenediol; Culture Techniques; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Dinoprost; Endometrium; Estrogen Antagonists; Female; Humans; Prostaglandins F; Tamoxifen | 1988 |
Hormone load tests in the first half of pregnancy--a diagnostic and therapeutic approach.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Spontaneous; Abortion, Threatened; Allylestrenol; Betamethasone; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Dehydroepiandrosterone; Endocrine Glands; Estradiol; Female; Hormones; Humans; Hydroxyprogesterones; Peptide Fragments; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Progesterone; Promegestone; Tamoxifen | 1984 |
Low-dose aminoglutethimide in treatment of advanced breast cancer.
Topics: Adrenal Glands; Aged; Aminoglutethimide; Breast Neoplasms; Castration; Dehydroepiandrosterone; Drug Evaluation; Estradiol; Estrone; Female; Humans; Middle Aged; Tamoxifen | 1984 |
Aminoglutethimide in tamoxifen-resistant patients: The Melbourne Experience.
Topics: Adrenal Glands; Adult; Aged; Aminoglutethimide; Breast Neoplasms; Dehydroepiandrosterone; Depression, Chemical; Drug Resistance; Drug Therapy, Combination; Female; Humans; Middle Aged; Tamoxifen; Testosterone; Time Factors | 1982 |
Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients.
Topics: Adrenal Cortex Hormones; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrogens; Estrone; Female; Humans; Hydrocortisone; Menopause; Tamoxifen | 1982 |
Inhibition of steroid sulfatase activity by danazol.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen | 1984 |
Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
Topics: Adrenocorticotropic Hormone; Aged; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Lymphocyte Culture Test, Mixed; Menopause; Middle Aged; Pregnancy Proteins; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin; Tamoxifen | 1982 |
Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.
Topics: Adrenal Cortex; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Ovary; Prednisone; Sex Hormone-Binding Globulin; Tamoxifen | 1980 |
Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens.
Topics: 17-Hydroxysteroid Dehydrogenases; Animals; Binding, Competitive; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Kinetics; Mammary Neoplasms, Experimental; Polyunsaturated Alkamides; Pregnenolone; Rats; Rats, Sprague-Dawley; Sulfatases; Tamoxifen | 1993 |
Effects of androgens on proliferation and progesterone receptor levels in T47D human breast cancer cells.
Topics: Androgens; Breast Neoplasms; Cell Division; Dehydroepiandrosterone; Dihydrotestosterone; Down-Regulation; Estradiol; Female; Flutamide; Humans; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1993 |
Chemoprevention of breast cancer.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Clinical Trials as Topic; Combined Modality Therapy; Cyclohexenes; Dehydroepiandrosterone; Estrogen Antagonists; Female; Genistein; Humans; Isoflavones; Limonene; Middle Aged; Monoterpenes; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Retinoids; Tamoxifen; Terpenes | 1996 |
Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland.
Topics: Animals; Anticarcinogenic Agents; Carbenoxolone; Carcinogens; Dehydroepiandrosterone; Diet; Drug Administration Schedule; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen | 1996 |
Changes in serum estrogen levels in women during tamoxifen therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Prospective Studies; Tamoxifen | 1997 |
Effects of oral administration of tamoxifen, toremifene, dehydroepiandrosterone, and vorozole on uterine histomorphology in the rat.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Dehydroepiandrosterone; Female; Mammary Neoplasms, Animal; Rats; Rats, Sprague-Dawley; Tamoxifen; Toremifene; Triazoles; Uterus | 2000 |
Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain.
Topics: Adjuvants, Immunologic; Animals; Brain; Dehydroepiandrosterone; Estradiol; Estrogen Antagonists; Female; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Estrogen; Receptors, Serotonin; Tamoxifen | 2000 |
Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system.
Topics: Antineoplastic Agents, Hormonal; Cell Division; Colonic Neoplasms; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Fluorouracil; Gene Expression; Gonadal Steroid Hormones; Growth Inhibitors; Humans; Inhibitor of Apoptosis Proteins; Ligands; Microtubule-Associated Proteins; Neoplasm Proteins; Protein Biosynthesis; Proteins; Quercetin; Receptors, Estrogen; Receptors, Progesterone; Steroids; Survivin; Tamoxifen; Telomerase; Testosterone; Thymidylate Synthase; Tumor Cells, Cultured | 2000 |
Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol.
Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Chromatography, Thin Layer; Dehydroepiandrosterone; Dexamethasone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immunoassay; Mitogens; Tamoxifen; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2001 |
Effect of beta-estradiol on voltage-gated Ca(2+) channels in rat hippocampal neurons: a comparison with dehydroepiandrosterone.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Androstenedione; Animals; Azlocillin; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dizocilpine Maleate; Estradiol; Estrogen Antagonists; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Hippocampus; Imidazolidines; N-Methylaspartate; Neurons; Nifedipine; Rats; Rats, Wistar; Tamoxifen | 2001 |
Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways.
Topics: Androgen Antagonists; Animals; Apoptosis; Chromones; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Fetal Proteins; Flutamide; Morpholines; Nerve Tissue Proteins; Neurons; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Signal Transduction; Tamoxifen; Telencephalon | 2002 |
Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) inhibit the apoptosis in human peripheral blood lymphocytes.
Topics: Adult; Apoptosis; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Flow Cytometry; Flutamide; Humans; Lymphocytes; Male; Middle Aged; Staurosporine; Tamoxifen | 2004 |
Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor.
Topics: Adjuvants, Immunologic; Animals; Aorta; Cattle; Cells, Cultured; Cyclic GMP; Dehydroepiandrosterone; Endothelium, Vascular; Enzyme Activation; Estrogen Antagonists; Estrogens; Humans; Mitogen-Activated Protein Kinase Kinases; Nitric Oxide; Nitric Oxide Synthase; Pertussis Toxin; Protein-Tyrosine Kinases; Receptors, Cell Surface; Tamoxifen; Time Factors; Umbilical Veins | 2004 |
Dehydroepiandrosterone restores depressed peripheral blood mononuclear cell function following major abdominal surgery via the estrogen receptors.
Topics: Abdomen; Adjuvants, Immunologic; Adult; Aged; Cells, Cultured; Cytokines; Dehydroepiandrosterone; Estrogen Antagonists; Female; Humans; Immunity, Cellular; Immunocompromised Host; Leukocytes, Mononuclear; Male; Middle Aged; Postoperative Complications; Prospective Studies; Receptors, Estrogen; Sepsis; Tamoxifen | 2005 |
Identification of a transcriptional fingerprint of estrogen exposure in rainbow trout liver.
Topics: Animals; Dehydroepiandrosterone; Diet; Diethylstilbestrol; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogens, Non-Steroidal; Gene Expression Profiling; Gene Expression Regulation; Glyceraldehyde-3-Phosphate Dehydrogenases; Image Processing, Computer-Assisted; In Situ Hybridization; Ligands; Liver; Oligonucleotide Array Sequence Analysis; Oncorhynchus mykiss; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA; Selective Estrogen Receptor Modulators; Tamoxifen; Transcription, Genetic | 2008 |
Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors.
Topics: Alcohol Drinking; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Sectional Studies; Dehydroepiandrosterone; Female; Gonadal Steroid Hormones; Humans; Leptin; Middle Aged; Peptides; Postmenopause; Sex Hormone-Binding Globulin; Surveys and Questionnaires; Survivors; Tamoxifen | 2008 |
Breast ductal lavage for assessment of breast cancer biomarkers.
Topics: Adult; Aged; Analysis of Variance; Androstenedione; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast; Breast Neoplasms; Cathepsin D; Dehydroepiandrosterone; Epidermal Growth Factor; Estradiol; Estrone; Female; Humans; Immunoassay; Middle Aged; Postmenopause; Premenopause; Progesterone; Tamoxifen; Therapeutic Irrigation | 2010 |
Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1).
Topics: Catalysis; Dehydroepiandrosterone; Enzyme Inhibitors; Humans; Pregnenolone; Proton Magnetic Resonance Spectroscopy; Sulfotransferases; Tamoxifen | 2014 |
Newer Name, Newer Treatments: The Genitourinary Syndrome of Menopause.
Topics: Adjuvants, Immunologic; Administration, Intravaginal; Atrophy; Dehydroepiandrosterone; Estrogens; Female; Female Urogenital Diseases; Humans; Lubricants; Menopause; Tamoxifen; Vagina; Vulva | 2019 |